Skip to main content
Omnicell, Inc. (OMCL)
NASDAQ: OMCL · Real-Time Price · USD
45.69
+1.58 (3.58%)
Nov 22, 2024, 4:00 PM EST - Market closed

Omnicell Revenue

Omnicell had revenue of $282.42M in the quarter ending September 30, 2024, a decrease of -5.44%. This brings the company's revenue in the last twelve months to $1.06B, down -10.26% year-over-year. In the year 2023, Omnicell had annual revenue of $1.15B, down -11.48%.

Revenue (ttm)
$1.06B
Revenue Growth
-10.26%
P/S Ratio
1.97
Revenue / Employee
$291,563
Employees
3,650
Market Cap
2.12B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.15B-148.84M-11.48%
Dec 31, 20221.30B163.93M14.48%
Dec 31, 20211.13B239.81M26.88%
Dec 31, 2020892.21M-4.82M-0.54%
Dec 31, 2019897.03M109.72M13.94%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Astrana Health 1.72B
Tandem Diabetes Care 854.35M
Amphastar Pharmaceuticals 723.55M
Azenta 656.32M
Supernus Pharmaceuticals 651.97M
NeoGenomics 644.12M
Beam Therapeutics 349.64M
Mirum Pharmaceuticals 307.03M
Revenue Rankings

OMCL News

More News